Aggressive Lipid Lowering Does Not Improve Endothelial Function in Type 2 Diabetes

Endothelial dysfunction is considered an important early marker of atherosclerosis and cardiovascular risk and is currently used as a surrogate end point for cardiovascular risk in clinical trials. Type 2 diabetic patients show a characteristic dyslipidemia. Aggressive lipid lowering might be an effective method to improve endothelial function in these patients.A randomized, double-blind, placebo-controlled trial was completed to study the...